legislation: 114-hr-6463
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114-hr-6463 | 114 | hr | 6463 | Patient Safety and Toxicology Modernization Act of 2016 | Health | 2016-12-07 | 2016-12-07 | Referred to the House Committee on Energy and Commerce. | House | Rep. Collins, Chris [R-NY-27] | NY | R | C001092 | 1 | Patient Safety and Toxicology Modernization Act of 2016 This bill requires the Food and Drug Administration to issue and periodically update guidance on: (1) novel tools for testing the toxicology and efficacy of medications, and (2) three-dimensional human tissue models. | 2023-01-11T13:33:55Z |